Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Prediabetes Screening Test Completed Within One Hour

By LabMedica International staff writers
Posted on 16 Feb 2009
A new test for point-of-care detection and management of diabetes and prediabetes produces results in less than one hour.

Called CeaProve, the test incorporates both of the conventional approaches for screening for diabetes and prediabetes--the fasting test and the glucose challenge test for diabetes. More...
This "two-in-one" test can identify individuals with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT).

CeaProve, a product of Ceapro (Edmonton, AB, Canada), consists of six highly calibrated wafers containing 50 g of glycemic carbohydrate, fat, and protein. Once consumed the glycemic carbohydrate causes a measurable rise in blood glucose that can be determined with a glucose meter. The level of this rise in blood glucose following an oral glucose challenge is indicative of a person's diabetic status.

Ceapro signed a research, license, and supply agreement for CeaProve with IR2Dx Inc. (San Francisco, CA, USA). The objective of the partnership is to use planned clinical studies to demonstrate a number of advantages in side effect profile, detection of true positives, shorter time to completion, and improved palatability of the CeaProve meal.

Ceapro and IR2Dx will jointly cover the development cost. Ceapro will remain responsible for the manufacturing of the product and will receive royalties on net sales in addition to regulatory milestones. IR2Dx will have worldwide marketing rights for the hospital, clinic, and physician market, exclusive except in Canada, where Ceapro has retained co-promotion rights.

IR2Dx specializes in the development of clinical assays for diagnostic uses for the evaluation and treatment of metabolic syndrome, cardiovascular inflammation, and insulin resistance.

Related Links:

Ceapro




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.